OrganiGram Holdings Inc. (OGI) Stock Forecast
OGI analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.40 / 5 from 5 analysts
- Price target
- $8.80 average of analyst targets
- Upside to target
- +849.3% from the latest close
- Next earnings
- —
- 52-week range
- $0.87 – $2.11
OGI analyst ratings
5 analystsNumber of analysts at each rating.
OGI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
OGI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $0.01 | $0.01 | $0.01 | $0.11 | −87.0% | 1 |
| Current fiscal year (FY2026) | $0.44 | $0.44 | $0.44 | −$0.10 | +535.1% | 1 |
| Next fiscal year (FY2027) | $0.02 | $0.02 | $0.02 | $0.44 | −94.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
OGI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Dec '26) | $111.5M | $103.0M | $121.2M | +75.4% | 4 |
| Current fiscal year (FY2026) | $349.8M | $346.9M | $351.6M | +34.9% | 5 |
| Next fiscal year (FY2027) | $458.1M | $445.0M | $474.5M | +31.0% | 5 |
OGI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
OGI revenue: reported and forecast
OGI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | — | 0 up · 0 down |
| Current fiscal year (FY2026) | $0.07 | $0.07 | $0.44 | $0.44 | $0.44 | +565.2% | 1 up · 0 down |
| Next fiscal year (FY2027) | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | +9.1% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
OGI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; OGI beat in 4 of 12.
What analysts expect from OGI
5 analysts cover OrganiGram; their consensus rating is buy (4.40 on a 1–5 scale, where 5 is a strong buy). The average price target is $8.80, 849.3% above the latest close of $0.93. Analysts expect earnings of $0.44 per share for FY2026, +535.1% from a year earlier. For FY2027 the average estimate is $0.02 per share on revenue of $458.1 million. OrganiGram beat the EPS estimate in 4 of the last 12 quarters.
Related: OGI income statement, OGI key metrics, OGI chart. See the OGI stock overview for the latest quote and news.
OGI forecast FAQ
What is OrganiGram's price target?
The average analyst price target for OrganiGram is $8.80, 849.3% above the latest close of $0.93.
Is OrganiGram a buy, hold or sell?
Of 5 analysts covering OrganiGram, 3 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is OrganiGram's EPS forecast?
Analysts forecast $0.44 per share for FY2026 (range $0.44 to $0.44); for FY2027 the estimate is $0.02.
What is OrganiGram's revenue forecast?
The average revenue estimate for FY2026 is $349.8 million, growth of 34.9%; for FY2027 it is $458.1 million.
Does OrganiGram usually beat earnings estimates?
OrganiGram reported EPS at or above the analyst estimate in 4 of the last 12 quarters.